Sierra Wireless Inc. (Nasdaq: SWIR) Shares Up

Sierra Wireless Inc. – Nasdaq: SWIR 

Shares of Sierra Wireless Inc. are up almost 9% on heavy volumes. SWIR is traded on the Nasdaq and ended Friday trading at $15.80 but today have reached $17.35.  

Canadian-based Sierra Wireless claims they are building the “Internet of Things”. They were first to market with: embedded software, embedded SIM, interchangeable modules, 4G LTE, and LTE Advanced solutions. They ship over 120 million M2M (machine to machine) devices worldwide and operate over 80 networks. Their IP catalog has over 400 patents. 

Sierra Wireless has impressive sales growth. In 2011 they reported $333.2 million in sales and in 2015 Sierra Wireless reported $607.8 million. Shareholders of SWIR have not seen similar performance. SWIR has an EPS loss of $1.62 in 2011 and a loss of $0.08 in 2015. SWIR has never experienced positive EPS.

Five firms follow Sierra Wireless. All five rate SWIR shares as a “Hold” with a consensus price target of $16. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

Biolase Inc. (Nasdaq: BIOL) Launches FDA Approved Laser

Biolase,Inc. – Nasdaq: BIOL 

Shares of BIOLASE, Inc. are up over 15% on heavy volumes. The company announced today its Epic Pro™ laser system, a new, innovative dental diode laser system that offers higher laser power than most diode lasers in dentistry, has received 510(k) clearance for commercial distribution from the U.S. Food and Drug Administration (FDA). The Epic Pro laser system, which received marketing authorization in select international markets late last year, can now be sold in the U.S. 

Irvine, CA-based Biolase trades on the Nasdaq under ticker symbol BIOL. Biolase, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells, and distributes dental imaging equipment, including CAD/CAM scanners. Biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing pain, fear, and anxiety. 

BIOL shares have never experienced positive EPS. In 2014 BIOL shares hit a low with a loss of $0.45 and in 2015 improved to a loss of $0.35. Sales have been relatively consistent. In 2011 reported sales were $48.9 million and in 2015 sales were $48.5 million. No firms or analysts currently rate BIOL shares.  

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/20/2017
Ticker Symbol BIOL
Last Price a/o 4:00 PM EST  $                      1.47
Average Volume 87,900
Market Cap $102 million
Sales $52.6 million
Shares Outstanding 69.39 million
Share Float 49.47 million
Shortable Yes
Optionable No
Inside Ownership 0.60%
Short Float 4.96%
Short Interest Ratio 27.93
Quarterly Return 14.84%
YTD Return 5.00%
Year Return 81.48%

Kornit Digital Ltd. (KRNT) 7 Million Shares Offered

Kornit Digital Ltd. – Nasdaq: KRNT

3D printer manufacturer Kornit Digital Ltd. today announced the launch of a public offering of an additional 7,000,000 ordinary shares. The Israeli-based firm will trade on the Nasdaq under ticker symbol KRNT.

Kornit Digital develops, manufactures and markets industrial and commercial printing solutions for the garment, apparel, and textile industries. Kornit Digital serves the digital textile printing industry with its NeoPigmentTM process including an integrated pretreatment solution, Kornit Digital caters to the needs of both designers and manufacturers. Kornit claims to be the only company to provide a complete digital printing solution, from start to finish.

2,000,000 of the shares are being offered by Kornit and 5,000,000 of the shares are being offered by shareholders of the company, substantially all by the company’s largest shareholder, Fortissimo Capital Fund II (Israel) L.P. Kornit and the selling shareholders have also granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares. Kornit intends to use the proceeds from the offering for general corporate purposes. The Company will not receive any of the proceeds from the sale of shares being offered by the selling shareholders.

Kornit Digital Ltd. is followed by four firms. Three rates KRNT shares as a “Strong Buy”. One rates KRNT as a “Buy”. Their consensus price target for KRNT is $18.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/20/2017
Ticker Symbol KRNT
Last Price a/o 4:00 PM EST  $                    17.75
Average Volume 128,250
Market Cap $542.88 million
Sales $102 million
Shares Outstanding 30.59 million
Share Float 29.44 million
Shortable Yes
Optionable No
Inside Ownership
Short Float 3.10%
Short Interest Ratio 7.12
Quarterly Return 74.02%
YTD Return 40.32%
Year Return 69.86%

ViewRay Inc. (Nasdaq: VRAY) Shares Higher on German Gov’t Purchase

ViewRay Inc. – Nasdaq: VRAY

 ViewRay Inc. shares are up over 25% on news that the German Research Foundation (DFG), a federal institution supporting research in Germany, has purchased a MRIdian Linac for installation and patient treatments at the University Clinic Heidelberg as part of its initiative for MRI-based radiation therapy. The shares are traded on the Nasdaq under ticker VRAY and are experiencing heavy trading volume this morning. 

ViewRay, Inc. designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients. In the United States, ViewRay has submitted a 510(k) application for the MRIdian Linac, the company’s MR Linac technology. Therefore, the MRIdian Linac is not available for sale or distribution in the United States except for non-clinical research use. 

ViewRay Inc. has experienced increasing sales figures. In 2012 the company reported sales of $1.9 million and in 2015 ViewRay reported sales of $10.4 million. However, EPS for shareholders of VRAY have experienced increasing negative EPS. In 2012 VRAY had an EPS loss of $0.66 and in 2015 VRAY had an EPS loss of $1.18. Two firms follow ViewRay and both rate VRAY shares as a “Strong Buy” with a $6 consensus price target. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/19/2017
Ticker Symbol VRAY
Last Price a/o 12:22 PM EST  $                      3.90
Average Volume 39,500
Market Cap $136.9 million
Sales $10.7 million
Shares Outstanding 43.61 million
Share Float 37.76 million
Shortable Yes
Optionable No
Inside Ownership 1.30%
Short Float 1.47%
Short Interest Ratio 14.11
Quarterly Return -19.28%
YTD Return 0.32%
Year Return

Oclaro, Inc. (Nasdaq: OCLR) Announces Preliminary Results – Shares Climb

Oclaro, Inc. – Nasdaq: OCLR

Oclaro, Inc. announced preliminary financial results after the market closed and shares are up over 8% on heavy volume. The San Jose, CA-based firm announced revenues at $153.5 – $154 million on prior guidance of $146 – $$154 million with gross margins of 40% versus prior guidance between 33% and 36%.

CEO Greg Dougherty commented in a press release – “Our excellent preliminary results for the December quarter once again demonstrated the strength of Oclaro’s products in the markets we serve. We expect revenue to come in at the high end of guidance as 100G and beyond sales again exhibited excellent growth.  In addition, we expect the quarterly results to reflect record levels of gross margin and operating income and exceed our prior guidance.  Our performance was driven by strong execution, a richer product mix, and favorable foreign exchange rates.”

Oclaro, Inc. develops optical components, modules, and subsystems for optical transport and metro networks, enterprise networks, and data centers. They trade on the Nasdaq under ticker OCLR. Ten firms follow Oclaro. Nine have rated OCLR shares as a “Strong Buy” and one rates OCLR as a “Hold”. The consensus price target is $11.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/18/2017
Ticker Symbol OCLR
Last Price a/o 5:25 PM EST  $                      8.84
Average Volume 5.36 million
Market Cap $1.36 Billion
Sales $455.9 million
Shares Outstanding 167.48 million
Share Float 157 million
Shortable Yes
Optionable Yes
Inside Ownership 2.90%
Short Float 10.17%
Short Interest Ratio 2.98
Quarterly Return 3.70%
YTD Return -9.16%
Year Return 135.65%

NVE Corporation (Nasdaq: NVEC) Posts Earnings

NVE Corporation – Nasdaq: NVEC

Eden Prarie, MN-based NVE Corporation announced financial results. The nanotechnology firm, traded on the Nasdaq under ticker NVEC, increased total revenue from $6.02 million in Q3 of the prior year quarter to $7.46 million. Net income for the third quarter of fiscal 2017 increased 35% to $3.48 million, or $0.72 per diluted share, compared to $2.58 million, or $0.53 per share, for the prior-year quarter. 

For the first nine months of fiscal 2017, total revenue decreased 1% to $21.5 million from $21.6 million for the first nine months of the prior year. The decrease was due to a 30% decrease in contract research and development revenue, partially offset by a 3% increase in product sales. Net income increased 2% to $9.92 million, or $2.05 per diluted share, for the first nine months of fiscal 2017 compared to $9.69 million, or $2.00 per share, for the first nine months of fiscal 2016. 

The company also announced a quarterly cash dividend to NVEC shareholders of $1.00 per share of common stock, payable February 28, 2017 to shareholders of record as of January 30, 2017.

 NVE Corporation is followed by one firm. Their analysts rate shares of NVEC as a “Strong Buy” with a price target of $66. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/18/2017
Ticker Symbol GRVY
Last Price a/o 4:00 PM EST  $                    70.69
Average Volume 13,800
Market Cap #343.2 million
Sales $26.1 million
Shares Outstanding 4.8 million
Share Float 4.74 million
Shortable Yes
Optionable No
Inside Ownership 0.10%
Short Float 0.92%
Short Interest Ratio 3.15
Quarterly Return 26.64%
YTD Return 0.10%
Year Return 41.42%

CyberOptics Corporation (Nasdaq: CYBE) Performing Well

CyberOptics Corporation – Nasdaq: CYBE

One year ago Cyberoptics corporation was trading under $10. Today the shares, traded on the Nasdaq under ticker CYBE, reached over $40.

CyberOptics Corporation is a developer and manufacturer of high precision sensing technology solutions. CyberOptics sensors are being used in general purpose metrology and 3D scanning, surface mount technology (SMT) and semiconductor markets to significantly improve yields and productivity. By leveraging its technologies, the company has strategically established itself as a global leader in high precision 3D sensors, allowing CyberOptics to further increase its penetration of its key vertical segments. Headquartered in Minneapolis, Minnesota, CyberOptics conducts worldwide operations through its facilities in North America, Asia, and Europe.

Cyberoptics Corporation earnings been inconsistent. In 2011 they reported a positive EPS of $0.63 but in the following years the company has reported annual EPS losses of $0.97, $0.91, $0.23, and $0.31. Likewise holders of CYBE have experienced inconsistent annoual sales figure since 2011 – $61.1 million, $41.6 million, $33.3 million, $46.5 million, and $41.1 million. Two firms follow CyberOptics Corporation and one rates CYBE shares as a “Strong Buy” and the other rates CYBE as a “Buy”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/18/2017
Ticker Symbol CYBE
Last Price a/o 2:17 PM EST  $                    39.02
Average Volume 91,000
Market Cap $230 million
Sales $64.2 million
Shares Outstanding 6.86 million
Share Float 6.75 million
Shortable Yes
Optionable No
Inside Ownership 1.90%
Short Float 1.58%
Short Interest Ratio 1.17
Quarterly Return 40.91%
YTD Return 28.93%
Year Return 309.87%

Gigamon Inc. (Nasdaq: GIMO) Provides Lower Guidance – Shares Dive

Gigamon, Inc. – Nasdaq: GIMO

Gigamon shares plunged in after-hours trading by over 20% after the company provided guidance that was below expectations. Traded on the Nasdaq under ticker GIMO, the shares ended the regular session at $44.05. However news of revenues coming in between $84 and $84.5 million in contrast to prior guidance of $92.2 million sent the shares to a after-hours low of $33.50.

Gigamon provides active visibility into physical and virtual network traffic enabling stronger security and superior performance. Gigamon’s Visibility Fabric™ and GigaSECURE®, the industry’s first Security Delivery Platform, deliver advanced intelligence so that security, network and application performance management solutions in enterprise, government and service provider networks operate more efficiently and effectively. With over ten years’ experience, Gigamon solutions are deployed globally across vertical markets including over seventy-five percent of the Fortune 100.

Eight firms follow Gigamon Inc. and three of those rate GIMO as a “Strong Buy”, one rates GIMO a “Buy”, and three rate GIMO a “Hold”. GIMO’s consensus price target is $58.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/17/2017
Ticker Symbol GIMO
Last Price a/o 6:06 PM EST  $                    34.65
Average Volume 833,900
Market Cap $1.59 Billion
Sales $292.9 million
Shares Outstanding 36.05 million
Share Float 32.36 million
Shortable Yes
Optionable Yes
Inside Ownership 1.30%
Short Float 9.08%
Short Interest Ratio 3.52
Quarterly Return -11.26%
YTD Return -3.29%
Year Return 96.21%

Applied Optoelectronics Inc. (AAOI) Surges in After-hours on Revised Revenue Projections

Applied Optoelectronics Inc. – Nasdaq: AAOI

Shares of Applied Optoelectronics Inc. surged over 20% in after-hours trading on news that future earnings will be above street estimates. AAOI revised revenue projections to between $84.5 and $84.8 million – well above previous projections between $75 and $79 million. Traded on the Nasdaq under ticker symbol AAOI, the shares ended the regular session at $22.72 however in the after-hours market the shares rose to $27.50.

Los Angeles, CA-based Applied Optoelectronics, Inc. designs, manufactures, and sells fiber-optic networking products primarily for internet data centers, cable television, and fiber-to-the-home networking end-markets.

From their press release:

“”We delivered a strong fourth quarter with top and bottom-line results expected to exceed our guidance,” said Dr. Thompson Lin, Applied Optoelectronics, Inc. founder, president and CEO. “Accelerated demand for our market-leading datacenter products and increased capacity fueled our results. Additionally, we continued to drive manufacturing efficiencies, which contributed to a record gross margin. We are excited by the good close to the year and look forward to sharing the additional details of our fourth quarter performance on our conference call in February.”

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/11/2017
Ticker Symbol SGNL
Last Price a/o 6:57 PM EST  $                    27.05
Average Volume 377,600
Market Cap $397.6 million
Sales $228.8 million
Shares Outstanding 17.5 million
Share Float 16.34 million
Shortable Yes
Optionable Yes
Inside Ownership 2.10%
Short Float 13.10%
Short Interest Ratio 5.67
Quarterly Return 3.09%
YTD Return -3.07%
Year Return 52.18%

Ichor Holdings Ltd. (Nasdaq: ICHR) Posts Results – Shares drop

Ichor Holdings, Ltd. – Nasdaq: ICHR

Shares of Ichor Holdings, Ltd. dropped after the firm released financial results for the 4th quarter and gave guidance for 2017. Ichor Holdings, Ltd. trades on the Nasdaq under ticker symbol ICHR.

Fremont, CA-based Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems for semiconductor capital equipment in the United States, the United Kingdom, Singapore, and Malaysia. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices. Ichor Holdings employees are strategically located to provide their customers with the highest level of customer service and support from their program management, sales, engineering, and executive management teams.

Ichor expects sales of approximately $131 million for the fourth quarter, and approximately $405 million for the 2016 fiscal year. Additionally, Ichor expects sales for the first quarter of the 2017 fiscal year to be higher than for the fourth quarter of the 2016 fiscal year.

Ichor Holdings has posted negative EPS in 2014 and 2015: -$0.02 and -$0.40 respectively. However sales increased from $249 million in 2014 to $290.6 million in 2015. Five firms follow Ichor Holdings with three rating ICHR a “Strong Buy” and two rating ICHR a “Buy”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/10/2017
Ticker Symbol ICHR
Last Price a/o 4:00 PM EST  $                    13.40
Average Volume 162,000
Market Cap $320.5 million
Sales $338.8 million
Shares Outstanding 23.92 million
Share Float 20.83 million
Shortable Yes
Optionable No
Inside Ownership 12.20%
Short Float 0.87%
Short Interest Ratio 1.12
Quarterly Return
YTD Return 23.84%
Year Return